30 Sep GE HealthCare Stock: Insights and Analysis
Did you know GE Healthcare Technologies Inc. has a $42 billion market cap? This huge number highlights its big role in the healthcare tech world. It shows us how important this titan is in the stock market1.
Are you following the latest GEHC stock forecast? Or maybe you’re diving deep into GEHC stock analysis. Keeping up with GE HealthCare stock market updates is key for smart investing. In this piece, we’ll explore everything about GE HealthCare stock. From recent changes to what experts predict, we aim to guide you through the evolving field of medical tech and healthcare services.
Key Takeaways
- GE Healthcare Technologies Inc. has a market cap of $42 billion1.
- Stock value fluctuates based on market conditions, financial reports, and industry trends2.
- Analyst recommendations and target prices offer insights into future stock performance2.
- The current intrinsic value of GEHC stock in a base case scenario is $93.421.
- GE HealthCare stock is considered to be 2% undervalued compared to its intrinsic value1.
- Historical performance data can be used to identify stock trends and patterns2.
Introduction to GE HealthCare Stock
GE HealthCare Technologies Inc. plays a key role in making healthcare tech worldwide3. Based in Chicago, Illinois, they offer a wide range of products. This includes Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics3.
What is GE HealthCare Technologies Inc.?
GE HealthCare is known for its strong products and services. These are essential for patient diagnosis, treatment, and monitoring. Founded in 2022, the company pushes for tech advances with partners like Mass General Brigham3. With nearly 51,000 workers, it made $19.6 billion in 2023 and a net income of $1.6 billion4.
Overview of the GEHC Stock
GEHC stock is a solid choice for investors, given its strong financials. It’s trading 24.8% below its estimated fair value. Plus, it’s expected to grow earnings by 12.6% each year3. GEHC has a market cap of $42.01 billion. It earned $1.58 billion with $19.52 billion in revenue3. Even with high debt, its past year’s return beat the US Medical Equipment industry and the overall US Market3.
Elite hedge funds often pick GEHC stock, with 49 holding it in Q2 20245. Its focus on AI innovations and hedge fund interest make it appealing. This suggests now might be a good time to buy GEHC stock for a diversified portfolio.
In recent updates, GE HealthCare reported $4.84 billion in Q2 2024 revenue5. This is an increase from the year before. Organic revenue grew by 1% and orders by 3% during the same period5. With its strong market presence and innovation, GEHC stock is expected to keep rising.
Latest GEHC Stock Price Trends
Recent GEHC stock price trends show the stock is doing well in the market. It last closed at $92.49, opened at $93.00, reached a high of $94.48, and a low of $91.896. This information suggests the stock is stable and could grow, important for investors.
Recent Performance Metrics
GEHC’s market capitalization is $42.01 billion, with a PE Ratio (TTM) of 26.847. This points to a stable valuation. The trading volume was much higher than average, showing strong investor interest6. Also, the stock has a modest dividend yield of 0.13% and an EPS of $3.477.
| Metric | Value |
|---|---|
| Previous Close | $92.49 |
| Open | $93.00 |
| High | $94.48 |
| Low | $91.89 |
| Volume | 12,623,820 |
| Revenue (TTM) | $19.52B |
| Profit Margin | 8.09% |
| Dividend Yield | 0.13% |
| Number of Employees | 51.00K |
Historical Performance Comparison
Looking at GEHC historical performance, the stock grew by 33.82% last year7. It hit a high of $94.55 and a low of $62.35 in the past 52 weeks6. With a beta of 0.91, it’s less volatile than the market7. The net income was $1.57 billion, showing strong performance7.
Investors examining the GEHC stock price trends should consider these metrics. They show where the stock currently stands and hint at future movements.
Key Financial Metrics for GEHC Stock
Looking into GEHC stock’s key financial numbers gives us a peek into its market success and future growth. GE HealthCare Technologies Inc. shows a strong financial structure, which is key for anyone thinking about investing.
Price-to-Earnings Ratio
The Price-to-Earnings (P/E) ratio of GEHC is at 26.6 now. It shows what investors think the company’s earnings will grow compared to its stock price8. A high P/E ratio may mean the stock costs too much or that investors believe it will do well in the future.
Earnings Per Share (EPS)
GE HealthCare Technologies Inc. has an EPS of $3.46 over the past twelve months9. This shows the company’s profit-making ability and its potential returns for shareholders. The expected adjusted EPS is $4.244 for this year8.
Market Capitalization
GEHC’s market cap is a whopping $42.2 billion. This ranks it in the top 95% of the Advanced Medical Equipment & Technology field8. Such a big market cap proves its strong position in the industry. This factor is crucial when evaluating GE HealthCare Technologies for investment.
Understanding the GEHC Stock Forecast
Those considering GE HealthCare stock should look into analyst price targets and growth estimates. These factors shine a light on GEHC stock’s possible future success.
Analyst Price Targets
Analysts predict varying price targets for GE HealthCare, with an average at $93.92. This suggests a 2.10% rise from the present $91.9910. The lowest target is $74.00 while the highest is $110.0010. These targets help us understand where the stock price may head.
Right now, GEHC stock’s price is steady, staying around $91.9911 after hours. This might calm investors worried about price jumps or falls.
Growth Projections
Looking ahead, GE HealthCare’s stock is likely to grow. By 2025, estimates show a price of $100.53, an 8.73% increase. By 2030, it could jump to $152.80, which is a 65.27% raise12.
Both past performances and latest advice reflect a bright future. The analyst consensus rates GE HealthCare as a strong buy, with a rating of 1.84. This suggests analysts see the stock doing well going forward.
Here’s how the stock’s price might climb over time:
| Year | Projected Price | Percentage Growth |
|---|---|---|
| 2025 | $100.53 | 8.73% |
| 2026 | $109.31 | 18.23% |
| 2027 | $118.86 | 28.56% |
| 2028 | $129.24 | 39.78% |
| 2029 | $140.53 | 51.99% |
| 2030 | $152.80 | 65.27% |
These forecasts give us a clear picture of GE HealthCare stock’s future. By understanding these price targets, you can make smarter choices in healthcare investments.
GEHC Stock News and Market Sentiments
The latest GEHC stock news is key for market feelings. It changes how investors think in the short and long run. News and analyst views help us see what’s shaping GE HealthCare Technologies Inc.
Latest News Releases
GE HealthCare’s news tells us about its strong moves. It reached a high market value of $42.01 billion USD, showing strong performance and trust from investors6. The company also made $19.55 billion USD in sales and got a net profit of $1.57 billion USD for the year7. Big new products and key alliances helped push the stock price up7.
Analyst Opinions and Ratings
Analysts give different views on GEHC stock, showing different feelings about the market. The stock’s P/E Ratio is 26.84, showing its potential growth and appeal6. Price predictions for GEHC stock stretch from $74.00 to $105.00 USD. This shows its future promise and how much experts trust it7. The company also has strong numbers, with an EPS of $3.47 USD and $2 billion USD in cash, adding to its financial strength67.
Keeping up with GEHC stock news and getting what experts think can help a lot when investing. With a profit rate of 8.09% and an ROE of 21.22%, GE HealthCare shows great results that match good market views6.
GEHC Stock Analysis: SWOT Overview
A GEHC SWOT analysis uncovers how GE Healthcare Technologies Inc. stands in the tough healthcare market. It looks at the company’s strong and weak points, chances for growth, and possible challenges.
Strengths
GE Healthcare shines with its varied products and cutting-edge tech solutions. Their excellent R&D efforts are shown by setting badge notifications to 5, showing dedication to new ideas13. Also, GE Healthcare’s alert system is top-notch, managing urgent news with just one try and a 2-second delay13.
Weaknesses
But, GE Healthcare has some weak spots. Their alert service tries only once for updates, which might delay crucial info14. Plus, their notifications might be slow, taking up to 1500 milliseconds to respond13.
Opportunities
GE Healthcare has big chances for growth. By increasing notifications in the panel to 6, they can improve outreach14. They can also engage customers better by using 100% of personalized alerts and subscription topics14.
Threats
However, GE Healthcare faces threats like regulatory changes and fierce competition. The shaky healthcare sector, with a need for up to 5 new alerts, poses risks14. The notification panel’s new alert indicator also shows the need to always be alert to stay competitive13.
Profitability and Income Statement Analysis
Looking into gehc profitability and the income statement gives deep insights into the company’s finances.
Revenue Growth
GE HealthCare’s revenues varied from $17.164 billion to $19.552 billion, showing moderate revenue changes over time15. The company saw a small drop of 1% in revenue from $4.7 billion in 2023 to $4.65 billion in 202416.
Net Income Margins
Net income margins show the company’s financial stability. Income for shareholders ranged from $1.385 billion to $13.846 billion15. In the first quarter of 2024, net income reached $374 million, a slight hike from $372 million the previous year16.
GE HealthCare has managed expenses well. Total expenses were between $14.444 billion and $17.117 billion15.
Return on Equity
GE HealthCare’s return on equity (ROE) impressively stands at 21.22%6. This signals good profit generation from shareholder’s equity. Moreover, values like an enterprise value to EBITDA ratio of 14.33 and a forward P/E ratio of 19.80 show strong potential for profit and future earnings6.
Further, EBIT ranges from $2.598 billion to $2.915 billion15. EBITDA also shows strong numbers between $3.231 billion to $3.540 billion15. For trading tips, check this link: maximize gains.
Valuation Measures of GE HealthCare Stock
Grasping the value of GE HealthCare stock is vital for investors. It involves understanding the real worth and seeing if the sales numbers make the stock a good buy. These insights help figure out if investing in GE HealthCare Technologies Inc. is a smart move.
Intrinsic Value Calculation
The calculated intrinsic value of GE HealthCare stock is $93.42 USD. This shows the stock is priced less than its true worth at the current market price of $91.99 USD according to analysts17. The Price-To-Earnings Ratio (TTM) is 26.74. This ratio comes from a share price of $91.99 and earnings per share of $3.4418. Suggesting GE HealthCare is trading below its fair value of $122.3, this could mean a good buying opportunity.
Price/Sales Ratio
The price to sales ratio stands at 2.16 for GE HealthCare Technologies. This ratio lets investors weigh the company’s market value against its sales9. It serves as a standard for evaluating if the stock price aligns with sales data. The company also shows good financial health with an Enterprise Value/Revenue ratio of 2.6x and an Enterprise Value/EBITDA ratio of 14.1x17.
Looking at these valuation measures helps us see GE HealthCare’s market stance. Its Price-To-Earnings Ratio is 26.5x. This is below the average of its peers at 37.7x17. Trading under its fair value, GE HealthCare stands out as an attractive pick for investors.
- Valuation Score: 5/6
- PEG Ratio: 2.1x
- Market Cap: US$42.01 billion
- Price-To-Earnings Ratio of 26.5x vs. Industry Average of 39.8x17
- Analysts’ Price Target Range: US$74.00 to US$105.00, average target being US$95.4417
| Metric | Value |
|---|---|
| Valuation Score | 5/6 |
| PEG Ratio | 2.1x |
| Market Cap | US$42.01 billion |
| Price-To-Earnings Ratio vs. Industry | 26.5x vs. 39.8x |
| Analysts’ Average Price Target | US$95.44 |
The intrinsic value and price to sales ratio are key in assessing GE HealthCare Technologies. Considering its market performance and valuation metrics, it remains an attractive option for investors.
Importance of GEHC’s Core Business Segments
Understanding GE HealthCare’s core segments is key to knowing its market role and growth potential. These segments add uniquely to GEHC’s overall strength. They include imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics. Together, they are the foundation of GEHC’s varied healthcare technology approach.
Imaging
Imaging tech is a mainstay of GEHC’s offerings, giving top solutions for medical imaging. This covers advanced MRI, CT, and X-ray systems that help in precise diagnosis and patient evaluation. For instance, GE Healthcare Technologies stock saw a big one-year jump of 34.72%, showing strong demand and innovation in imaging19.
Ultrasound
The ultrasound sector is critical for GEHC, providing cutting-edge diagnostic instruments used across many medical scopes. These tools play a big role in obstetrics, cardiology, and emergency medicine. GEHC’s commitment to evolving ultrasound tech underlines its aim to boost diagnostic abilities and patient care.
Patient Care Solutions
GEHC’s Patient Care Solutions offers key medical devices and services for effective patient monitoring and care. It involves ventilators, anesthesia units, and monitoring gear vital in clinics. This segment meets the demand for dependable technologies in patient care, significantly aiding revenue growth.
Pharmaceutical Diagnostics
Pharmaceutical diagnostics is essential, with GEHC delivering contrast media drugs for imaging tests. This area’s success highlights GEHC’s broad healthcare market approach, serving both equipment and drug needs. Remarkably, GE Healthcare filed for about 6,125 patents in the last 20 years, with nearly 4,000 granted, proving its drive for innovation and leadership19.
GEHC Stock in the Context of Market Competitors
It’s important to know how GE HealthCare (GEHC) stacks up against its rivals. When we look closely, we find key points that show where GEHC stands. These insights help us see GEHC’s place in the competition.
Comparative Analysis with Peers
In 2022, GE HealthCare Technologies Inc. made a strong showing with sales of $18.34 billion20. This performance puts them ahead of many in the field. Their earnings per share growth is also impressive, making them a standout21. GEHC’s price-to-earnings (P/E) ratio gives it an edge, boosting trust among investors21.
The company’s share of the healthcare equipment market is solid, thanks to its varied products and global presence21. Plus, a price-to-earnings-growth ratio of 3 points to strong future growth20.
Market Position and Competitive Edge
GEHC stands out because of its well-known brand and global reach. The health sector is evolving fast, with new tech and increasing demands20. GEHC stays ahead by embracing trends like AI and digital health, which opens new doors for them22.
Strong cash flow shows GEHC is financially healthy. This allows them to keep investing in research and development20. Their focus on innovation keeps them leading in areas like precision medicine and genomic testing22.
In short, GE HealthCare Technologies Inc. stands out with a strong market position. Its edge comes from a wide-ranging portfolio, ongoing innovation, and smart positioning against competitors21.
Buy GEHC Stock: Is It a Good Investment?
When you think about buying GEHC stock, you’ll notice the company’s strength. GE HealthCare Technologies Inc. had a revenue of $4.84 billion in the second quarter of 2024. This was a 0.46% increase from the year before5. They also saw 1% organic revenue growth and a 3% uptick in orders. This shows they’re doing well in the healthcare market5.
Today, GEHC’s stock price is $91.9923. The company has 12,621,619 shares and a whopping market cap of $42.61 billion235. GEHC ranks in the top 30% in the Medical Info Systems sector. This shows it has a big impact on the market23.
GEHC stock looks promising for several reasons. The company scored ‘A’ in value, growth, and momentum. This suggests it’s a solid choice for investors23. With a cash/price ratio of 0.05 and an EV/EBITDA of 16.23, GEHC’s financial state looks strong. Analysts have also shared positive insights about its performance23.
GE HealthCare stock has a Zacks Rank of 3-Hold23. This means analysts have a balanced opinion on it. Its recent -0.50 (-0.54%) change shows the kind of movement you can expect from this stock23.
Looking at all this info helps understand GEHC stock’s potential. By reviewing detailed data, you can make a smarter choice about investing in it. This helps decide if GE HealthCare Technologies Inc. fits your investment strategy.
Sell GEHC Stock: When Should You Consider It?
Selling GEHC stock might be smart if the market conditions change a lot. For example, if the healthcare sector goes down, this could make the stock do worse in the future.
If GE HealthCare’s money situation gets worse, think about selling. Recent info shows about 80.1% of GEHC’s shares were given to GE’s stockholders. GE kept around 19.9%24. This shows GE believes in the stock, but things can change.
Also, look at the company’s strategy. GE HealthCare’s shares are on The Nasdaq under “GEHC.” This makes the shares easy to buy or sell, which might affect your decision24. Being updated on such details is key.
The right time to sell also depends on outside things. Like if healthcare laws or the global economy changes a lot. These can impact GE HealthCare a lot, maybe making selling a smart move. Watching the market closely helps in deciding.
Let’s look at important investment considerations for selling GEHC stock:
- Changes in healthcare laws
- How well the company is doing
- What the market trends are
- Big company decisions
- Changes in the world economy
The details from the spin-off give more clues. The important dates were December 16, 2022, and January 3, 2023. This lined up with similar big companies24. These points help figure out when to sell your GEHC stock.
In the end, selling GEHC stock needs deep understanding of the market conditions and how the company is doing. Always use the newest info and strategies to get the best from your investment.
Risks and Challenges for GE HealthCare Stock
Investing in GE HealthCare has risks and challenges. It’s important to know about the strict healthcare laws and how market changes can affect stock performance.
Regulatory Risks
Healthcare rules play a big role in GEHC stock risks. Changes in laws might slow down new products or force the company to change its market plans. For example, the company’s worth was $45 billion at the end of last quarter. But, money spent on following rules affects its financial results25.
The healthcare field is full of regulations. Policy changes can really affect GE HealthCare’s work and place in the market. It’s vital for GE HealthCare to follow all these rules to avoid fines and delays, which can lower potential income26.
Market Volatility
Changes in the market are also a big risk for GE HealthCare stock. The stock went up by 11% since the year started. Yet, there was a swing of 12.5% in the last six months. This shows how sensitive it is to market shifts25. Such swings can make it hard to guess the stock’s future.
A debt-to-equity ratio of 115.6% adds to the risk in unpredictable markets. High debt can cause financial problems when the economy is unstable3. This means the company needs a good plan to get through tough times and protect investor money.
Even with these issues, GE HealthCare could bounce back. Its revenue might grow by 12.6% per year. This suggests it could recover and grow despite uncertain markets3. But, it’s key for investors to understand how market changes affect GEHC stock risks.
Knowing these risks with healthcare rules and market changes can help investors. They can better handle and lessen possible losses.
For more insights into GE HealthCare stock and its recent trends, check this detailed report26.
Conclusion
After looking closely at GE HealthCare stock, you’ve got a complete picture. We explored their finances, market actions, and future. Despite a small drop in revenue to $4.65 billion27 and a 14.28% fall in stock price28, there’s good news too.
Important numbers, like the P/E ratio at 29.328, show GE HealthCare stands strong against others. The company also sees growth, especially in pharmaceutical diagnostics with a sales boost27.
We should look at how GE plans to face challenges and grow. With a $42.61 billion market cap5, the company is worth your attention. Deciding to buy or hold? Keep analyzing and watch the market to make smart choices.